Latest News

CX International Symposium 2025 Unveils its Podium First Sessions
Written by: CX International Symposium 2025
CX International Symposium 2025 Unveils its Podium First Sessions
First Commercial Implant Of the Gore® Excluder® Conformable AAA Endoprosthesis With Active Control System in Canada
Written by: Gore Medical
First Commercial Implant Of the Gore® Excluder® Conformable AAA Endoprosthesis With Active Control System in…
Late-Breaking Trail and Featured Clinical Research Presentations Revealed for ACC Scientific Sessions 2025
Written by: ACC 2025
Late-Breaking Trial and Featured Clinical Research Presentations Revealed for ACC Scientific Sessions 2025
New Data: 70% of Americans Unaware of Common Vascular Disease That is One of the Leading Causes of Amputation
Written by: PAD Pulse Alliance
New Data: 70% of Americans Unaware of Common Vascular Disease That is One of the Leading Causes of…
Findings from an Apolipoprotein B-Based Genetic Analysis
Written by: Radcliffe Cardiology
New Study Finds Lipoprotein(a) More Atherogenic Compared to LDL
ISET 2024 Late-Breaking Science Revealed
Written by: ISET
ISET 2024 Late-Breaking Science Revealed
Written by: VIVA Foundation
20 Late-Breaking Clinical Trials To Be Presented at The VEINS and VIVA 2023
Latest AI technology improves echocardiogram reproducibility and repeatability
Written by: EchoNous
Latest AI technology improves echocardiogram reproducibility and repeatability
Written by: Bentley Global
Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent
Bentley Acquired the GoBack Catheter
Written by: Bentley
Bentley Acquired the GoBack Catheter

External news

Written by: Cardiac Vascular News
Imperative Care Announces Appointment of Todd Van Horn to Chief Financial Officer
Written by: Cardiac Vascular News
Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
Written by: Cardiac Vascular News
Vivasure Medical Receives CE Mark Approval in Europe for PerQseal Elite Vascular Closure System
Written by: Cardiac Vascular News
Gentuity® Expands Executive Leadership Team to Drive Next Phase of Growth and Innovation
Written by: Cardiac Vascular News
Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025
Written by: Cardiac Vascular News
Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
Written by: Cardiac Vascular News
Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
Written by: Cardiac Vascular News
R3 Vascular Announces First Patient Treated in ELITE-BTK Pivotal Trial for Below-the-Knee PAD Using MAGNITUDE® Drug Eluting Bioresorbable Scaffold
Written by: Cardiac Vascular News
FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA
Written by: Cardiac Vascular News
Transverse Medical Inc. Announces Completion of First Series of Patients in Feasibility Clinical Study at Victorian Heart Hospital, Melbourne, Australia, Using Point-Guard Cerebral Embolic Protection.